DiNuzzo Private Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History

DiNuzzo Private Wealth’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.27K	Hold	6	–	–	﹤0.01%	619
2026 Q2	$1.76K	Hold	6	–	–	﹤0.01%	725
2026 Q1	$1.67K	Hold	6	–	–	﹤0.01%	708
2025 Q4	$1.82K	Hold	6	–	–	﹤0.01%	684
2025 Q3	$1.79K	Hold	6	–	–	﹤0.01%	674
2025 Q2	$1.45K	Buy	6 +2	+50%	+$473	﹤0.01%	736
2025 Q1	$975	Sell	4 -2	-33%	-$602	﹤0.01%	838
2024 Q4	$1.97K	Buy	6 +5	+500%	+$1.7K	﹤0.01%	610
2024 Q3	$335	Hold	1	–	–	﹤0.01%	1213
2024 Q2	$274	Buy	+1	New	+$291	﹤0.01%	1208
2024 Q1	–	Sell	-4	Closed	-$1.29K	–	1370
2023 Q4	$1.29K	Buy	+4	New	+$1.25K	﹤0.01%	607

Other funds holding BIO

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

PFGIA

Patriot Financial Group Insurance Agency Westborough, Massachusetts $1.05B AUM 21.28% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.73B AUM 18.92% 1-Year Est. Return

DiNuzzo Private Wealth's BIO Position: Q3 2026 in Review

DiNuzzo Private Wealth held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 6 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

DiNuzzo Private Wealth first reported a position in BIO in Q4 2023 and has held it in 11 quarters since. 28 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

DiNuzzo Private Wealth held 6 shares of Bio-Rad Laboratories Class A worth $2.27K as of Q3 2026.
DiNuzzo Private Wealth left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #619 holding.
DiNuzzo Private Wealth first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 11 quarters since.
28 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.